TETRADECYL HYDROGEN SULFATE (ESTER)

TETRADECYL HYDROGEN SULFATE (ESTER) was reported 85 times

These side effects are most commonly reported by patients taking TETRADECYL HYDROGEN SULFATE (ESTER):

# Side effect Count
0 INJECTION SITE HAEMATOMA 10
1 HYPERSENSITIVITY 9
2 INJECTION SITE DISCOLOURATION 9
3 ULCER 7
4 ERYTHEMA 6
5 INJECTION SITE PAIN 5
6 DRUG INEFFECTIVE 4
7 ESCHAR 4
8 LOSS OF CONSCIOUSNESS 4
9 AIR EMBOLISM 3
10 CELLULITIS 3
11 HYPOAESTHESIA 3
12 NAUSEA 3
13 PAIN IN EXTREMITY 3
14 PRODUCT USE IN UNAPPROVED INDICATION 3
15 SKIN NECROSIS 3
16 VOMITING 3
17 ACCIDENTAL EXPOSURE 2
18 ANAPHYLACTIC REACTION 2
19 ANAPHYLACTIC SHOCK 2
20 APHASIA 2
21 CEREBROVASCULAR ACCIDENT 2
22 DIZZINESS 2
23 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2
24 EXPOSURE DURING BREAST FEEDING 2
25 FATIGUE 2
26 HEADACHE 2
27 HEMIPARESIS 2
28 HYPERTENSION 2
29 INFLAMMATION 2
30 INJECTION SITE ERYTHEMA 2
31 INJECTION SITE ULCER 2
32 MUSCLE SPASMS 2
33 NECROSIS 2
34 NEUROPATHY PERIPHERAL 2
35 POST PROCEDURAL COMPLICATION 2
36 PROCEDURAL COMPLICATION 2
37 PRODUCT QUALITY ISSUE 2
38 PRODUCT SUBSTITUTION ISSUE 2
39 ROAD TRAFFIC ACCIDENT 2
40 SCAR 2
41 SKIN DISCOLOURATION 2
42 SKIN ULCER 2
43 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2
44 VARICOSE ULCERATION 2
45 WOUND 2
46 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2
47 ABSCESS LIMB 1
48 ACCIDENTAL EXPOSURE TO PRODUCT 1
49 ACIDOSIS 1
50 ACNE 1
51 ALOPECIA 1
52 ANAPHYLACTOID REACTION 1
53 ANGINA PECTORIS 1
54 ARTHRALGIA 1
55 ASTHENIA 1
56 BLINDNESS 1
57 BLOOD CREATININE INCREASED 1
58 BLOOD PRESSURE INCREASED 1
59 BLOOD UREA INCREASED 1
60 BONE LOSS 1
61 BURNING SENSATION 1
62 CARDIAC ARREST 1
63 CARDIAC FAILURE CONGESTIVE 1
64 CEREBRAL ARTERY EMBOLISM 1
65 CHEST DISCOMFORT 1
66 CHEST PAIN 1
67 CHROMATURIA 1
68 COUGH 1
69 DEHYDRATION 1
70 DEVICE DISLOCATION 1
71 DIARRHOEA 1
72 DISEASE RECURRENCE 1
73 DRUG TOXICITY 1
74 DYSGEUSIA 1
75 DYSPNOEA 1
76 EAR DISCOMFORT 1
77 EXPIRED PRODUCT ADMINISTERED 1
78 EYE IRRITATION 1
79 EYE SWELLING 1
80 FALL 1
81 FAMILY STRESS 1
82 FEAR 1
83 FEELING ABNORMAL 1
84 FLUSHING 1
85 FORMICATION 1
86 GASTROINTESTINAL DISORDER 1
87 GENERALISED TONIC-CLONIC SEIZURE 1
88 GLOMERULOSCLEROSIS 1
89 GRANULOMA ANNULARE 1
90 HEPATIC CYST 1
91 HEPATIC FAILURE 1
92 HOSPITALISATION 1
93 HYPERHIDROSIS 1
94 HYPOTENSION 1
95 IMPAIRED HEALING 1
96 INFECTION 1
97 INFLUENZA 1
98 INJECTION SITE EXTRAVASATION 1
99 INJECTION SITE INFLAMMATION 1
100 INJECTION SITE INJURY 1
101 INJECTION SITE IRRITATION 1
102 INJECTION SITE SWELLING 1
103 INJECTION SITE VESICLES 1
104 INTESTINAL OBSTRUCTION 1
105 JOINT SWELLING 1
106 LETHARGY 1
107 MIGRAINE 1
108 MULTIPLE ALLERGIES 1
109 MUSCULAR WEAKNESS 1
110 MYALGIA 1
111 NASOPHARYNGITIS 1
112 NECROSIS ISCHAEMIC 1
113 NEPHRITIS ALLERGIC 1
114 NEPHROPATHY TOXIC 1
115 NEURALGIA 1
116 NIH STROKE SCALE SCORE INCREASED 1
117 NO ADVERSE EVENT 1
118 OEDEMA PERIPHERAL 1
119 ORAL DISCOMFORT 1
120 OVERDOSE 1
121 OXYGEN SATURATION DECREASED 1
122 PAIN 1
123 PARAESTHESIA 1
124 PARKINSON^S DISEASE 1
125 PATELLA FRACTURE 1
126 PERIPHERAL SWELLING 1
127 PHYSICAL PRODUCT LABEL ISSUE 1
128 POISONING 1
129 PRE-EXISTING CONDITION IMPROVED 1
130 PRESYNCOPE 1
131 PROTEINURIA 1
132 PULMONARY ARTERY OCCLUSION 1
133 PULMONARY EMBOLISM 1
134 RASH 1
135 REFUSAL OF TREATMENT BY PATIENT 1
136 RENAL DISORDER 1
137 RENAL FAILURE 1
138 RENAL FAILURE ACUTE 1
139 RESTLESS LEGS SYNDROME 1
140 RETINAL ARTERY EMBOLISM 1
141 SCAB 1
142 SEIZURE 1
143 SENSORY DISTURBANCE 1
144 SENSORY LOSS 1
145 SEPSIS 1
146 SERRATIA INFECTION 1
147 SHOCK 1
148 SKIN EXFOLIATION 1
149 SURGERY 1
150 SWELLING 1
151 SWELLING FACE 1
152 SYNCOPE 1
153 TENDERNESS 1
154 THERAPEUTIC RESPONSE SHORTENED 1
155 THERAPEUTIC RESPONSE UNEXPECTED 1
156 TINNITUS 1
157 TOOTH EXTRACTION 1
158 TREATMENT NONCOMPLIANCE 1
159 TREMOR 1
160 TUBULOINTERSTITIAL NEPHRITIS 1
161 UPPER LIMB FRACTURE 1
162 UROSEPSIS 1
163 URTICARIA 1
164 VASCULITIS 1
165 VEIN DISORDER 1
166 VISION BLURRED 1
167 VISUAL BRIGHTNESS 1
168 VISUAL IMPAIRMENT 1
169 WEIGHT BEARING DIFFICULTY 1
170 WHEEZING 1
171 WRIST FRACTURE 1